Lawrence I. Karsh

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

Karim Fizazi, Michael A. Carducci, Matthew R. Smith et al. · The Lancet · 2011 · 1.9K citations · Full text

Urology, Surgical Oncology, Medicine +9

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

Matthew R. Smith, Fred Saad, Robert E. Coleman et al. · The Lancet · 2011 · 792 citations · Full text

Urology, Oncology, Genitourinary Cancer +6

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety et al. · The Lancet Oncology · 2020 · 412 citations · Full text

Urology, Oncology, Genitourinary Cancer +2

A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer

Dipen J. Parekh, Sanoj Punnen, Daniel D. Sjoberg et al. · European Urology · 2014 · 402 citations

Usa Confirms, Urology, Cancer Epidemiology +9

Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy

Neil Mariados, John Sylvester, Dhiren Shah et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 399 citations · Full text